IP Library Granted Patent US 7,559,481
Granted Patent B2
US 7,559,481 · App. 10/807,616 · Granted Jul 14, 2009

Differentiable spectral bar code methods and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,559,481
App. No.
10/807,616
Granted
Jul 14, 2009
Kind
B2
Abstract

Devices, systems, methods, and compositions of matter can track and/or identify a library of elements, particularly for use with fluids, particulates, cells, and the like. Signals from one or more semiconductor nanocrystals may be combined to define spectral codes. Separation of signal wavelengths within dedicated wavelength ranges or windows facilitates differentiation of spectral codes, while calibration signals within the spectral codes can avoid ambiguity. Modeling based on prior testing can help derive libraries of acceptable codes.

Claims (12)

1. A method for identifying a plurality of identifiable elements, in the method comprising: energizing a plurality of labels so that a first marker of each label generates a first signal with a first wavelength peak at least some of the labels comprising multiple-signal label having a second marker generating a second signal with a second wavelength peak; measuring the first wavelength peaks, wherein each label comprises at least one reference marker, wherein the reference marker generates a reference signal that is used for calibrating the spectrum for the label;

for each multiple-signal label, measuring the second wavelength peak at least a predetermined minimum wavelength separation for the associated first peak; and

identifying the labels in response to the measured peaks.

2. The method of claim 1 , wherein the labels comprise semiconductor nanocrystals.

3. The method of claim 2 , wherein the semiconductor nanocrystals comprise CdS, CdSe, CdTe, ZnTe, InP, InAs, InSb, PbS, PbSe or a ternary or quaternary mixture or alloy thereof.

4. The method of claim 3 , wherein the overcoating layer is or comprises ZnS, GaN, MgS, MgSe, MgTe, CdS, CdSe or a ternary or quaternary mixture or alloy thereof.

5. The method of claim 2 , wherein the semiconductor nanocrystal further comprises an overcoating layer.

6. The method of claim 1 , wherein each predetermined minimum wavelength separation is at least as large as a full width half maximum (FWHM) of at least one of the associated first peak and the associated second peak.

7. The method of claim 1 , wherein the labels are associated with polymeric beads.

8. The method of claim 7 , wherein the polymeric beads comprise a polymer selected from polystyrene, polyacrylics, polysiloxanes, polymeric silica, latexes, dextran polymers, and epoxies.

9. The method of claim 1 , wherein the identifiable elements are cells or biological matter.

10. The method of claim 1 , wherein the labels comprise a fluorescent material.

Assignments (5)
LIEN RELEASE Recorded Apr 8, 2013
From: BANK OF AMERICA, N.A.
To: QUANTUM DOT CORPORATION
Reel/Frame 030173/0867 →
CHANGE OF NAME Recorded Jun 3, 2009
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 022776/0529 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: QUANTUM DOT CORPORATION
To: BANK OF AMERICA, N.A.
Reel/Frame 021932/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2005
From: QUANTUM DOT CORPORATION
To: INVITROGEN CORP.
Reel/Frame 016862/0372 →
SECURITY AGREEMENT Recorded Feb 16, 2005
From: QUANTUM DOT CORPORATION
To: INSTITUTIONAL VENTURE PARTNERS VII, L.P.; INSTITUTIONAL VENTURE MANAGEMENT VII, L.P.; ABINGWORTH BIOVENTURES IIA LP; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP2; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP3; SV NOMINEES LIMITED ON BEHALF OF SCHRODER VENTURES INVESTMENTS LIMITED; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II GROUP CO-INVESTMENT SCHEME; SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II STRATEGIC PARTNERS LP; FRAZIER HEALTHCARE III, L.P.; FRAZIER AFFILIATES III, L.P.; BB BIOVENTURES L.P.; MPM ASSET MANAGEMENT INVESTORS 2000 A LLC; MPM BIOVENTURES PARALLEL FUND, L.P.
Reel/Frame 015687/0106 →